Zenas BioPharma

ZBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.047 B

$32.43 +0.81%

Close of 7 Aug 2026

Revenue

$10.0M

#3169 by revenue

Earnings

-$377.7M

Loss-making

Shares outstanding

63,133,377

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#111GH ResearchGHRS$2.08B
#112Aurinia PharmaceuticalsAUPH$2.06B
#113Zenas BioPharmaZBIO$2.05B
#114AbCellera BiologicsABCL$2.04B
#115Ocular TherapeutixOCUL$2.02B

Where these numbers come from

Share counts and financials for Zenas BioPharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.